JAGX
Price
$1.18
Change
-$0.18 (-13.33%)
Updated
Dec 1 closing price
Capitalization
5.04M
Intraday BUY SELL Signals
LGVN
Price
$0.63
Change
-$0.03 (-4.55%)
Updated
Dec 1 closing price
Capitalization
13.59M
Intraday BUY SELL Signals
Interact to see
Advertisement

JAGX vs LGVN

Header iconJAGX vs LGVN Comparison
Open Charts JAGX vs LGVNBanner chart's image
Jaguar Health
Price$1.18
Change-$0.18 (-13.33%)
Volume$97.63K
Capitalization5.04M
Longeveron
Price$0.63
Change-$0.03 (-4.55%)
Volume$592.79K
Capitalization13.59M
JAGX vs LGVN Comparison Chart in %
JAGX
Daily Signal:
Gain/Loss:
LGVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JAGX vs. LGVN commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Hold and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 02, 2025
Stock price -- (JAGX: $1.17 vs. LGVN: $0.64)
Brand notoriety: JAGX and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 70% vs. LGVN: 123%
Market capitalization -- JAGX: $5.04M vs. LGVN: $13.59M
JAGX [@Biotechnology] is valued at $5.04M. LGVN’s [@Biotechnology] market capitalization is $13.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 0 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 4 TA indicator(s) are bullish while LGVN’s TA Score has 3 bullish TA indicator(s).

  • JAGX’s TA Score: 4 bullish, 5 bearish.
  • LGVN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, JAGX is a better buy in the short-term than LGVN.

Price Growth

JAGX (@Biotechnology) experienced а -7.87% price change this week, while LGVN (@Biotechnology) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.58%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +56.80%.

Industries' Descriptions

@Biotechnology (+1.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGVN($13.6M) has a higher market cap than JAGX($5.04M). LGVN has higher P/E ratio than JAGX: LGVN (2.95) vs JAGX (0.04). LGVN YTD gains are higher at: -63.173 vs. JAGX (-95.366). LGVN has higher annual earnings (EBITDA): -18.35M vs. JAGX (-38.75M). LGVN has more cash in the bank: 10.3M vs. JAGX (2.21M). LGVN has less debt than JAGX: LGVN (1.14M) vs JAGX (30.5M). JAGX has higher revenues than LGVN: JAGX (11.8M) vs LGVN (2.07M).
JAGXLGVNJAGX / LGVN
Capitalization5.04M13.6M37%
EBITDA-38.75M-18.35M211%
Gain YTD-95.366-63.173151%
P/E Ratio0.042.951%
Revenue11.8M2.07M569%
Total Cash2.21M10.3M21%
Total Debt30.5M1.14M2,675%
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGXLGVN
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signal:
Gain/Loss:
LGVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDTG0.480.09
+22.02%
CDT Environmental Technology Investment Holdings Limited
UNTY50.360.33
+0.66%
Unity Bancorp
ITT182.25-1.56
-0.85%
ITT
TUSK1.78-0.06
-3.26%
Mammoth Energy Services
TXG18.07-0.74
-3.93%
10x Genomics

JAGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAGX has been loosely correlated with RXRX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if JAGX jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
-13.33%
RXRX - JAGX
35%
Loosely correlated
-5.72%
FGEN - JAGX
34%
Loosely correlated
-2.27%
CDIO - JAGX
31%
Poorly correlated
+0.07%
RNAZ - JAGX
31%
Poorly correlated
N/A
MRNA - JAGX
31%
Poorly correlated
-7.01%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with BIVI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-4.01%
BIVI - LGVN
51%
Loosely correlated
+0.47%
HRTX - LGVN
44%
Loosely correlated
-0.86%
RXRX - LGVN
40%
Loosely correlated
-5.72%
QURE - LGVN
37%
Loosely correlated
-3.42%
SNGX - LGVN
36%
Loosely correlated
-4.72%
More